CASCO, ME–(Marketwire – September 2, 2010) –  Camp Sunshine, a one-of-a-kind national retreat in Casco for children with life-threatening illnesses and their families, today announced that Hyundai Hope on Wheels has selected the organization to receive a $100,000 “Hope Grant.” Hope on Wheels is a partnership of 800 Hyundai dealers across the United States and Hyundai Motor America aimed at raising awareness of childhood cancer. Camp Sunshine will use funds from the grant to sponsor two additional oncology sessions at the Camp in 2011.

On Sept. 25 — during National Childhood Cancer Awareness Month — Hope on Wheels will visit Camp Sunshine’s Casco campus and participate in a check presentation ceremony to commemorate the event. Throughout the month, Hope on Wheels will travel to all 68 Hope Grant recipients to present the donations and hear from children, their families and all of those involved in the fight against cancer.

“While we’ve made progress over the last few decades and now have an 85 percent cure rate, cancer still takes more lives than any other childhood disease,” said John Krafcik, President and CEO of Hyundai Motor America. “This September, in support of Childhood Cancer Awareness Month, Hyundai will shine a nationwide spotlight on this cause and provide more than $6 million in grants for pediatric cancer research and support programs. We love taking on big challenges at Hyundai, and we can think of no more worthy challenge than finding a cure for all forms of pediatric cancer.”

Located in Maine’s scenic Sebago Lake region, Camp Sunshine features a 23-acre lakeside campus with private family suites, as well as a climbing wall, indoor swimming pool and computer learning center — all of which are free of charge to all families. To date, Camp Sunshine has welcomed families from 47 states and 17 countries.

“Camp Sunshine is delighted and humbled to receive this generous donation from Hyundai,” said Matt Hoidal, executive director, Camp Sunshine. “This investment will enable us to expand our programs in 2011 and bring nearly 1,000 children and their families much needed respite, support, and hope. We thank Hyundai and their network of dealers in Northern New England and around the country for helping us continue our service and contributions to the cancer community.”

About Camp Sunshine
Camp Sunshine offers children with life-threatening illnesses and their families a place to relax together for a week, and to take a break from the extraordinary demands placed upon them on a daily basis. The year-round program is free of charge and staffed almost entirely by volunteers. It is the only program in the nation whose mission is to address the impact of a life-threatening illness on every member of the immediate family — the ill child, the parents and the siblings. Since its inception in 1984, Camp Sunshine has provided a haven for more than 32,000 individuals from diverse cultural backgrounds. In addition to providing 24-hour on-site medical and psychosocial support, the camp offers a variety of daily activities, including swimming, boating, archery and soccer, and special events such as bonfires and cookouts. To support Camp Sunshine, please call (207) 655-3800 or visit www.campsunshine.org.

About Hyundai Motor America
Hyundai Motor America, headquartered in Fountain Valley, Calif., is a subsidiary of Hyundai Motor Co. of Korea. Hyundai vehicles are distributed throughout the United States by Hyundai Motor America and are sold and serviced through more than 800 dealerships nationwide.

About Hyundai Hope on Wheels
Hyundai Hope on Wheels™ is the united effort of more than 800 Hyundai dealers across the U.S. to raise awareness about childhood cancer and celebrate the lives of children battling the disease. By the end of 2010, Hope on Wheels will have awarded more than $23 million dollars to children’s hospitals and non-profit organizations across the U.S. to support the fight against childhood cancer.

DALLAS, TX–(Marketwire – September 2, 2010) –  Metiscan, Inc. (PINKSHEETS: MTIZ) announced today shareholder points of interest discussed during the Company’s nationwide teleconference yesterday. Mr. Bryan A. Scott, President & CEO, and Mr. Brian Hart, COO of Metiscan, provided deeper insight into its subsidiaries’ markets, products, and near term objectives, as well as Metiscan’s pursuit in listing on the OTCBB.

During the Teleconference, Mr. Scott detailed Metiscan’s corporate structure as the parent company of a portfolio of enterprises with operations in healthcare, healthcare IT, mobile technology and employment services. Metiscan manages all aspects of its subsidiaries and is currently pursuing growing its subsidiary Taptopia through technologies that are unique to its products and through acquisitions that complement its subsidiaries’ operations. Metiscan’s four subsidiaries are FirstView EHR, Inc., Taptopia, Inc., Schuylkill Open MRI, Inc. and Shoreline Employment Services, Inc. Mr. Scott further discussed Metiscan’s recent filing of its registration statement and its goal to meet the OTC Market requirements to qualify for the OTCBB market tier.

Mr. Scott also mentioned how Taptopia was founded in July 2009 with the vision of applying new technologies to the $80 Billion convention, trade show and meeting industry that revolutionize the way show managers and event organizers do business. Mr. Scott stated that, “the industry is greatly in need of technologies, more specifically software technologies, that aid exhibitors and attendees to realize more value from their events, as well as aid show managers with tools that help increase attendance and reduce costs.” He also summarized that Taptopia’s goal is to create and roll out new patent protect software technologies, which Taptopia has in its pipeline.

Bryan Hart, COO of Metiscan, mentioned that the Company is trending in a positive manner. Mr. Hart explained how Metiscan realized approximately $2.5M in revenues for year-end 2009, a 144% increase from year-end 2008. During 2010, the Company’s revenues have continued to increase over the last two quarters. Mr. Hart stated, “This quarter alone we experienced a 47% increase in our revenues, or $165,439 from the same period in 2009.” Mr. Hart also mentioned that during the first half of 2010 Metiscan experienced a 16% increase in its revenues, a $194,111 gain. The Company’s overall revenues as of June 30, 2010 were $1,413,490.

Mr. Hart stressed the importance of how digital medical information, specifically the electronic healthcare record systems FirstView administers and Schuylkill Open MRI recently implemented, saves the medical industry time and money. He stated that, “Metiscan strongly believes that storing medical information digitally, and being able to distribute it electronically, is a great cost savings by itself.” Mr. Hart also mentioned that last year $19 billion in the stimulus package targeted physicians to use electronic health record systems because EHR technology cuts costs, eliminates paperwork and helps doctors deliver high quality, coordinated care to patients. Mr. Hart explained that this will benefit Metiscan both for its imaging center as it relates to the benefit of the operational efficiencies EHR provides, and for FirstView as it relates to the professional Healthcare IT services it provides.

Mr. Hart explained how Metiscan demonstrated positive income from operations during the first half of 2010 totaling $184,464. Mr. Hart mentioned that Metiscan has constantly been focused on increasing operational efficiencies in all of its subsidiaries. Mr. Hart gave the example of how Schuylkill Open MRI moved towards more economical service contracts for maintaining all of its MRI equipment in its diagnostic imaging center and recently implemented a new EHR system. With FirstView, Mr. Hart said it reduced costs related to operating its data center and the amount of personnel needed for its billing and collection activities. He summarized his discussion on Metiscan’s subsidiaries, pointing out that Shoreline, its employment services division, has focused on economies of scale as it relates to personnel resources and benefits.

In closing, Mr. Scott stated, “We are very excited about our business activities here at Metiscan. We have great expectations for our company and our team believes in its future. We have been successful in building a company that is displaying both financial growth and innovation in new products and technologies.”

A recording of Metiscan’s nationwide teleconference will be available on the Company’s website at: www.metiscan.com within the next few days.

About Metiscan, Inc.

Metiscan, Inc. (Metiscan) (PINKSHEETS: MTIZ) is the parent company of a portfolio of enterprises with operations in healthcare, healthcare IT, mobile technology and employment services. Metiscan manages all aspects of its subsidiaries and is currently pursuing acquisitions that complement its subsidiaries’ operations. Metiscan’s subsidiaries include FirstView EHR, Inc., Taptopia, Inc., Schuylkill Open MRI, Inc., Shoreline Employment Services, Inc. For more information visit www.metiscan.com

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Metiscan’s actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms “believes,” “belief,” “intends,” “anticipates” or “plans” to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.

LONDON–(Marketwire – September 2, 2010) –  Genome Research Group (GRG) (PINKSHEETS: KKUR) recently announced its intended merger with ChromoCure, Inc. and consolidation of the operations and technologies of both groups. Genome Research Group personnel have assumed all executive and board duties and have no current or planned operations in the USA.

The company intends to open permanent offices in the United Kingdom as well as establish the first of several planned research labs and testing partners.

To date, the Company has not been able to secure its previously anticipated investment capital due to the declining USA economy and capital markets. The Company believes it has now secured satisfactory capital commitments and will proceed with its business plan accordingly.

The Company’s objectives are:

1. Recapitalize the company’s stock structure and change the company’s trading symbol to trade under “Genome Research Group.”

2. Establish business offices and permanent address in the United Kingdom with the most likely location being London.

3. Structure the company’s operations as decentralized management with multiple operational hubs and team members around the world.

4. Secure initial research lab space for the Company’s ongoing research and development for both its cancer imaging systems as well as its therapeutic protocols and animal modeling experiments.

5. Appoint industry leaders to the Company’s Board of Advisors.

6. Partner with cancer labs and pathology labs within the European Union. The Company does not believe the USA healthcare market will be an open market inviting of innovation or new ideas. The Company has no immediate plans to seek partnerships within the USA due to healthcare over-regulation and control by the US government.

7. Complete and deploy company branding, image, and professional design of marketing and educational materials.

8. File updated financial information with appropriate legal opinion letter to achieve “Current” reporting status. The Company has no immediate intent to become a “SEC Reporting” company due to the massive expense and liability of that status.

The Company intends to release updates from time to time as these actions are completed.

About Genome Research Group
Genome Research Group develops and provides proprietary cancer detection systems and related therapeutic technologies. The Company’s proprietary cancer detection system locates and measures unique genomic characteristic found in 100% of all cancers and never found in normal cells. The Company’s proprietary Therapeutic Modeling Protocols provide statistical modeling and prediction tools for the measurement and monitoring of cancer progression and remission. GRG owns proprietary techniques for non-toxic and non-invasive cancer therapy utilizing hypothermic modulation and resonance.

Safe-Harbor Statement
This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.

SPRINGFIELD, OH–(Marketwire – September 2, 2010) –  AdCare Health Systems, Inc. (NYSE Amex: ADK), a recognized innovator in senior living and health care facility management, has closed the lease of three nursing homes according to the previously announced agreement to lease five additional nursing homes in Georgia.

The three nursing homes, which have been leased under a 10-year term, have an aggregate of 280 beds that generate approximately $15.5 million in annualized revenue. With the addition of these three facilities and other transactions closed earlier in the year, AdCare’s estimated annualized revenue run-rate now exceeds $79 million, as compared to $26.7 million for the year ended 2009.

Upon closing of the lease transaction, AdCare provided the lessor $195,000 for the first month’s lease payment and a portion of the security deposit, with the balance of $337,000 to be paid over five months comprising the balance of the security deposit and an amount equal to two months lease payments.

“This transaction is the third we’ve closed since we began our M&A campaign at the end of last year,” said Chris Brogdon, AdCare’s vice chairman and chief acquisitions officer. “We expect all of these facilities to be significant cash generators for AdCare, especially as they come under our highly capable management and benefit from our larger economy of scale.”

“As we work toward closing the currently pending transactions we’ve announced, including the lease of the remaining two nursing homes in Georgia, additional opportunities continue to emerge in the southern region of the U.S.,” said Brogdon. “We are working to establish the terms and necessary financings for several new potential acquisitions in our pipeline of equal or greater potential.”

Brogdon joined AdCare last September when the company announced a new M&A growth strategy to build upon its strong reputation for operational efficiency and high-quality living environments.

About AdCare Health Systems
AdCare Health Systems, Inc. (NYSE Amex: ADK) is a recognized innovator in senior living and health care facility management. AdCare develops, owns and manages assisted living facilities, nursing homes and retirement communities, as well as provides home health care services. Since its inception in 1988, AdCare’s mission has been to provide the highest quality of healthcare services to the elderly. For more information about AdCare, visit www.adcarehealth.com.

Important Cautions Regarding Forward-Looking Statements
 Statements contained in this press release that are not historical facts may be forward-looking statements within the meaning of federal law. Such statement can be identified by the use of forward-looking terminology, such as “believes,” “expects,” “plans,” “intends,” “anticipates” and variations of such words or similar expressions, but their absence does not mean that the statement is not forward-looking. Statements in this announcement that are forward-looking include, but are not limited to, statements that the company expects all of these new facilities to be significant cash generators for AdCare. Such forward-looking statements reflect management’s beliefs and assumptions and are based on information currently available to management. The forward-looking statements involve known and unknown risks, results, performance or achievements of the Company to differ materially from those expressed or implied in such statements. Such factors are identified in the public filings made by the Company with the Securities and Exchange Commission and include the Company’s ability to secure lines of credit and/or an acquisition credit facility, find suitable acquisition properties at favorable terms, changes in the health care industry because of political and economic influences, changes in regulations governing the industry, changes in reimbursement levels including those under the Medicare and Medicaid programs and changes in the competitive marketplace. There can be no assurance that such factors or other factors will not affect the accuracy of such forward-looking statements.

Click here to see all recent news from this company

REDWOOD CITY, CA–(Marketwire – September 1, 2010) – AeroScout, the leading provider of Unified Asset Visibility for the healthcare industry, today announced continued strong growth in its healthcare business, extending its global lead in the healthcare market. 2009 was a record year for AeroScout healthcare revenue, and subsequent to that, the first half of 2010 represented the strongest two quarters in the company’s history for AeroScout’s Healthcare Real-Time Location System (RTLS). In those two quarters, AeroScout received more than 200 orders for its healthcare solutions, which provide real-time visibility into the location, status and condition of assets, patients and staff, from healthcare organizations around the world. One of the main reasons for the rapid adoption is that, with AeroScout’s Wi-Fi RFID solutions, organizations are able to leverage their existing, standard Wi-Fi infrastructures instead of deploying and maintaining separate proprietary networks. 

“In addition to its comprehensive set of Healthcare RTLS solutions and integration capabilities, AeroScout offers hospitals the opportunity to save money while reducing risk and complexity by using their Wi-Fi networks instead of proprietary networks,” said Gregg Malkary, Managing Director of Spyglass. “This means its clients don’t need to purchase, wire and maintain an overlay network, and it has led to rapid growth for AeroScout and Wi-Fi RFID over the past few years.”

Complementing the Wi-Fi advantages, other factors that have contributed to AeroScout’s increasing market leadership include its track record with top hospitals and healthcare systems around the world, its robust suite of solutions, and the ease with which AeroScout solutions integrate with other healthcare information systems, hospital equipment and business processes.

AeroScout has completed implementations at hundreds of healthcare organizations, covering every major region of the world — North America, Australia, Europe, Asia, the Middle East and Latin America. The experience gained over the years from these customers and deployments has continued to increase AeroScout’s healthcare expertise and customer base. Examples of global healthcare customers include:

• Adventist Health System, Winter Park, Florida, USA
• Macquarie University Hospital, Sydney, Australia
• GZA Hospital Group, Antwerp, Belgium
• Akita University Hospital, Akita, Japan
• Hospital Israelita Albert Einstein, São Paulo, Brazil

AeroScout’s comprehensive solutions allow customers to work with a single, proven provider and implement one platform for all current and future asset, patient and staff visibility needs. This includes enterprise-wide asset and people tracking, room-level location, bay-level (sub-room) resolution, optional chokepoint detection, condition monitoring and passive RFID applications.

Focusing on the needs of its global healthcare customers, AeroScout is continuously expanding and enhancing its robust set of healthcare applications, which includes Asset Management, Condition Monitoring, Patient Flow and Patient & Staff Safety. For example, the company recently enhanced its Patient Flow and Patient & Staff Safety solutions by designing and producing the world’s smallest Wi-Fi Tag for patients and staff. AeroScout also supplemented its Condition Monitoring offerings with Humidity Monitoring Solutions, which include Wi-Fi Tags and end-user software.

AeroScout’s range of integrations with healthcare information systems is the broadest in the RTLS market. AeroScout offers integrations with nurse call systems, maintenance management systems, infusion pumps, security and building automation systems, VoIP communication devices and more. For example, AeroScout now integrates with the Rauland-Borg Responder 5 Nurse Call system to enable improved clinician efficiency and workflow. AeroScout also provides MobileView for VoIP Phones, which delivers AeroScout’s end-user software on VoIP communication devices to enhance staff productivity, mobility and communication.

“To serve our multiplying healthcare customer base, we continue to develop and enhance solutions to drive additional value for our clients,” said Yuval Bar-Gil, CEO of AeroScout. “Hospital and healthcare organizations across the globe are using AeroScout’s Wi-Fi-based solutions to reduce capital and operational expenses, increase staff efficiency, facilitate regulatory compliance and improve patient care.”

About AeroScout
AeroScout is the market leader in Unified Asset Visibility solutions. Customers improve operational efficiency using AeroScout products that leverage standard Wi-Fi networks to track and manage the location, condition and status of mobile assets and people. AeroScout’s global customer base consists of leading hospital, manufacturing and logistics organizations, including many of the Fortune 500. The company invented the first Wi-Fi-based Active RFID tag, and today is widely recognized as leading the market in number of deployments and tags shipped. Headquartered in Redwood City, California, AeroScout has offices in Europe, the Middle East, Asia, Australia and Latin America. For more information, please visit www.aeroscout.com.

AeroScout is a registered trademark of AeroScout, Inc. Wi-Fi is a trademark of the Wi-Fi Alliance. All other trademarks are the property of their respective owners. Information is subject to change without notice.

MAUMEE, OH–(Marketwire – September 1, 2010) –  After completing several months of rigorous due diligence following the signing of a definitive agreement to bring the two organizations together, the transaction is now complete and St. Luke’s Hospital has officially become a member of ProMedica Health System.

“We are thrilled that St. Luke’s has joined ProMedica,” says Randy Oostra, President and CEO of ProMedica. “Both organizations are dedicated to achieving the same overarching Mission: to improve the health of the people we serve. St. Luke’s joining ProMedica will help facilitate collaborative endeavors to better address critical health and social needs throughout the community. In the near term and for generations to come, it is imperative that organizations such as ours seek to achieve more effective and efficient clinical integration as we expand access to exceptional care.” 

“We have a promise at St. Luke’s — ‘Patients First. Always.’ Becoming a member of ProMedica allows us to continue to expand on that proud tradition of service and compassionate care,” says Dan Wakeman, President/CEO of St. Luke’s Hospital. ”Both organizations have much to learn and share with each other. We each have unique and distinguishing characteristics, and as we join ProMedica we have the opportunity to find synergies and build on the strengths of both our cultures.”

The most visible initial change the community and employees will notice is that St. Luke’s will now be included in the Paramount Health Care network. As a result, Paramount members and ProMedica employees will have access to St. Luke’s services. In addition, St. Luke’s employees will have access to ProMedica services and facilities through Medical Mutual’s Ohio SuperMed Plus network. 

“The due diligence we have conducted over the last several months has been intense and detailed,” says Barbara Steele, President, Acute Care, ProMedica Health System. “Yet, in many ways, the work starts now as teams begin the process of analyzing which services should be integrated to achieve efficiencies.”

The goal of service line and clinical integration is to:

• provide convenient and easier access to programs and services;
• provide a comprehensive continuum of care;
• enhance the physician’s ability to care for patients and improve quality-of-life issues;
• look for opportunities to create “Best in Class” programs to better serve patients and communities; and
• evaluate ways to add value to existing services.

“Nationwide, resources are shrinking while the need for top-quality health care has never been higher,” says Oostra. “With St. Luke’s as a member of ProMedica, we will be better able to proactively provide more effective and efficient coordination of care — and that will position us ahead of the health care reform curve and help meet the critical needs of our communities.”

About St. Luke’s Hospital
Located in Maumee, St. Luke’s Hospital is a full-service community hospital. Each year, this non-profit health care organization cares for more than 235,000 patients. Its 1,500 employees and 600 physicians provide a wide range of inpatient and outpatient services including high-risk cardiac surgery, oncology, labor and delivery, medical/surgical, critical and emergency care.

St. Luke’s is the only hospital in northwest Ohio to be ISO 9001:2008 certified, representing a highly collaborative accrediting process that encourages innovation in health care. The hospital is regularly recognized by third-party quality ratings organizations that rank St. Luke’s within the top 10% of hospitals nationally, based on outcomes, cost and patient satisfaction. For more information, visit www.stlukeshospital.com

About ProMedica Health System
ProMedica Health System, a mission-based organization that is ranked among the Top 5 most integrated health systems in the U.S., was formed in 1986 and is a Toledo, Ohio-based, not-for-profit healthcare organization with nearly 15,000 employees; 2,900 physicians and more than 283 facilities in Ohio and Michigan. ProMedica serves more than 2.4 million patients annually and includes 10 hospitals; ProMedica Continuum Services with senior, hospice, rehabilitation, and integrative services; ProMedica Physician Group, a network of more than 300 primary care, obstetrics and specialist physicians; and Paramount Health Care, the largest HMO in northwest Ohio. For more information, please visit www.promedica.org.

HILLSIDE, NJ–(Marketwire – September 1, 2010) – Infirmed children at St. Joseph’s Children’s Hospital in Paterson, New Jersey, will get to talk via a video connection with U.S.A.F. Air Combat Command Pilots, and view aerial demonstrations, before the official start of the “Thunder Over the Blue Ridge Open House & Air Show” in Martinsburg, West Virginia. The video event takes place 1-2 PM EDT on Friday, September 3, 2010 at the Giggles Children’s Theatre, located at St. Joseph’s Children’s Hospital, 703 Main Street, Paterson, NJ. This opportunity is sponsored by ”Operation: Aviators for Kids,” a partnership involving a Cisco video connection provided by Core BTS, managed services donated by Glowpoint, and Polycom videoconferencing end-point technology provided by Medical Missions for Children at the Giggles Children’s Theater.

About “Thunder Over the Blue Ridge” Open House & Air Show
The 167th Airlift Wing is proud to be hosting the “Thunder Over the Blue Ridge Open House & Air Show” on September 4 – 5, 2010. Building on the success of the 2008 Spirit of America Over Martinsburg Air Show, the 167th Airlift Wing, along with the Eastern West Virginia Regional Airport and the United Way of the Eastern Panhandle, will be bringing together some of the nation’s most exciting aerial demonstration teams, including the U.S. Air Force Thunderbirds, U.S. Air Force A-10 Demo East, U.S. Navy F-18 Hornet, and U.S. Army Golden Knights.

About St. Joseph’s Children’s Hospital
St. Joseph’s Children’s Hospital at St. Joseph’s Regional Medical Center is a leader in comprehensive health care for children. Recognized for our high standard of quality responsive and compassionate pediatric care, St. Joseph’s is a state designated children’s hospital offering a broad spectrum of services for patients from birth to 21 years of age — and their families.

When children are ill or injured, their condition and treatment can affect their overall development in ways that are important to foresee. That is why we say we “treat the whole child,” and have implemented a team approach to treatment. The various pediatric specialists at St. Joseph’s Children’s Hospital share their knowledge and experience to identify and anticipate complications that may impact the child’s state-of-mind and future development.

Blazing new paths in leading-edge technology and care, St. Joseph’s Children’s Hospital practices family-centered care. We strive to make children and families feel safe and to help them understand, and cope with, the challenges of illness.

About Glowpoint
Glowpoint, Inc. (OTCBB: GLOW) enables video users to effortlessly and securely call one another regardless of their video technology or network. With unlimited, “open” access to Glowpoint’s cloud-based, hosted-video infrastructure and services, video calling within — and between — companies is dramatically simplified. From full-featured telepresence and video conferencing suites to desktop video, Glowpoint supports customers around the world with 24/7 managed services that allow business professionals to enjoy “in-the-same-room” intimacy and cost savings. To see a video-in-the-cloud demonstration, and to learn more about how cost-effective and easy telepresence and video conferencing can be for your business, email us at contactme@glowpoint.com or visit http://www.glowpoint.com.

About Core BTS, Inc.
Core BTS, Inc. is a business technology infrastructure company that first seeks to understand you and your business, then helps you utilize technology to move your business forward. Headquartered in Madison, WI with 11 offices in six states, Core BTS delivers unified communications, data center, video, enterprise architecture and security solutions. See www.corebts.com to find an office near you or contact our headquarters at wisconsin@corebts.com or by phone at (608) 661-7700.

About Medical Missions for Children
Founded in 1999, Medical Missions for Children is dedicated to the mission of providing quality healthcare to critically-ill children throughout the world. It is an organization that knows no geographic boundaries and to date has successfully implemented 108 medical treatment and education programs in as many countries. Tapping into the volunteer spirit of the North American medical community, MMC hosts a consultative and educational support network for healthcare providers in developing nations who often lack the resources and specialty knowledge needed to successfully diagnosis and treat an infinite number of medical conditions.

The name of MMC’s communications infrastructure is the Global Telemedicine & Teaching Network™ (GTTN). The GTTN is a satellite- and Internet-based communications system that features an ever-expending digitized, video-based medical library, a global satellite-broadcast TV station (Medical Broadcast Channel – MBC), and an Internet Protocol (IP) supported, real-time, videoconference-based, remote diagnostics capability. The distribution of medical knowledge transported across the GTTN is supported by a network of 27 U.S.-based medical institutions, whose medical expertise is leveraged first to support a fully interactive telemedicine system and secondly to build a repository of medical content that is subsequently broadcast over MMC’s satellite and Internet2 distribution platforms. The GTTN is also used to broadcast live and pre-recorded child entertainment programming designed to touch the lives of hospitalized children throughout the U.S. and overseas.

Click here to see all recent news from this company

SAN FRANCISCO, CA–(Marketwire – September 1, 2010) –  Eye M.D.s are intent on finding better ways to diagnose and treat glaucoma, a complex, potentially blinding disease. September’s Ophthalmology journal includes new data from the Rotterdam Study that will help doctors better predict visual field loss in glaucoma patients. Johannes R. Vingerling, MD, PhD, Erasmus Medical Center, The Netherlands, and his colleagues followed 6,630 participants for ten years. The patients had optic nerve damage but no VFL when they joined the study. Ophthalmology is the journal of the American Academy of Ophthalmology. 

Worldwide, glaucoma is the most frequent cause of preventable blindness, but up to 80 percent of people who have the disease are unaware of it and so do not receive treatment that could help save their sight. Primary open angle glaucoma (POAG) is the most common form of the disease in the United States and many other countries. Visual field loss (VFL) is the shrinking of the “scope” of what a person can see; it usually begins as a loss of side (peripheral) vision in people who have POAG.

If untreated, POAG causes irreversible blindness. This occurs through progressive loss of the nerve cells in the eye’s retina, which leads to abnormal changes in the optic nerve. Over time, these changes can reduce the field of vision (visual field) and also disrupt the transmission of images to the brain’s vision center. 

“In this patient population, the risk of developing VFL was related to higher intraocular pressure (pressure within the eye, IOP), older age, a high level of myopia (nearsightedness), male gender, a family history of glaucoma, and a higher vertical cup-to-disk ratio (a measurement of the optic nerve head),” said Dr. Vingerling. His team’s data also provide an estimate of the long-term incidence of VFL in an older, white European population.

Higher IOP often contributes to POAG, and patients with high IOP (a condition also called ocular hypertension) are carefully monitored by their ophthalmologists.

Eye M.D.s also use the visual field test as a screening device to identify patients who might be developing glaucoma (or other eye diseases that affect the visual field) and who need comprehensive eye exams to determine their exact diagnosis.

Eds: Full text of the study is available from the Academy’s media relations department.

About the American Academy of Ophthalmology
The American Academy of Ophthalmology is the world’s largest association of eye physicians and surgeons — Eye M.D.s — with more than 29,000 members worldwide. Eye health care is provided by the three “O’s” — opticians, optometrists and ophthalmologists. It is the ophthalmologist, or Eye M.D., who can treat it all: eye diseases and injuries, and perform eye surgery. To find an Eye M.D. in your area, visit the Academy’s Web site at www.aao.org.

CALGARY, ALBERTA–(Marketwire – Sept. 1, 2010) –

WHAT: Next Wednesday, September 8, marks the grand opening of Brite Studios’ (Brite’s) new location. Brite Studios, formerly known as Calgary Children’s Centre, is Calgary’s premier childcare and recreational facility. At their launch event, Brite will demonstrate how they are working to improve the quality and amount of childcare services in our ever-growing city. 

As part of the event, there will be a creative ribbon-cutting ceremony as well as a brief performance by some of the children who attend Brite Studios. There will also be interactive artwork involving the attendees. The Honourable Ron Liepert and Alderman Joe Connelly will be in attendance to show their support. They will be addressing the audience with a few words on the importance of Brite Studios.

Representatives of Brite Studios, local and provincial government and academics will be gathering to celebrate the new name and location of this important centre for child learning and recreation.

WHO: In attendance will be:

Alberta Energy Minister Ron Liepert

Alderman Joe Connelly

Lisa Davis, Founder and CEO of Brite Studios

WHEN: Wednesday, September 8, 2010 

10:00 a.m. 

*Media are requested to arrive at 9:45 a.m. sharp.

WHERE: 

Brite Studios

Unit 148, 30 Springborough Blvd SW

Calgary, AB T3H 0N9

*Photo opportunities are available.

*Click here for map.

CENTERVILLE, MA–(Marketwire – September 1, 2010) –  UV Flu Technologies, Inc. (OTCBB: UVFT) (the “Company”) announced today that the improved features added to its UV-400 air purifier have been generating a surprising amount of interest from distributors.

The Company recently began coating the inside of its patented UV-400 cartridge with a thin layer of the photo-catalyst Titanium Dioxide (TiO2). Combined with the germicidal UV lamps contained within the cartridge, and moisture in the air, the hydroxyl radicals produced by the TiO2 accelerate the breakdown of molecular bonds present as odors or in the case of Volatile Organic Compounds (“VOC”). These compounds are converted into harmless water vapor and carbon dioxide, which results in significantly reducing the concentration and effects of odors and VOC’s.

“Volatile Organic Compounds, such as acetone, formaldehyde, benzene, as well as hundreds of other compounds, are surprisingly common in offices or households, and can be harmful in even small concentrations to people with respiratory problems, especially children and the elderly,” stated Jack Lennon, President of UV Flu Technologies. “Carpets, building materials, cleaning supplies, paints and varnishes, vinyl floors and furniture, air fresheners, copiers and printers, pesticides, secondhand smoke, wood burning stoves, nail polish remover and hair products; are all just a small sample of the products emitting VOC’s, many of which cause allergic reactions, as well as many of them containing known carcinogens. The UV-400 product has undergone laboratory tests which show the concentration of VOC’s are reduced significantly with each pass, which is repeated several times per hour in a typical room.”

“Many of our customers are very excited about this feature,” commented Bill Fegley, President of Puravair, a major distributor of UV Flu products. “The reduction of the concentration of these compounds and odors is considered very important to a wide array of our customer base, such as salons, health clubs, funeral homes, restaurants and athletic facilities. This feature, combined with the UV-400′s proven ability to kill bacteria, make it a compelling purchase for any location that commonly finds these types of airborne contaminants present in the course of their day-to-day operations.”

Further details regarding the Company’s business, financial reports and agreements are filed as part of the Company’s continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission’s (“SEC”) EDGAR database.

About UV Flu Technologies, Inc. (OTCBB: UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality (“IAQ”) industry sector. The Company manufactures the VIRATECH UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. The FDA has issued a coveted Class II medical listing that enables UV Flu Technologies to market the product as a medical device.

Notice Regarding Forward-Looking Statements
This news release contains “forward-looking statements” as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

ON BEHALF OF THE BOARD

UV Flu Technologies, Inc.
—————————–
John J. Lennon, President & CEO

Click here to see all recent news from this company